DE69434199D1 - Absorptionsförderer für topische pharmazeutische formulierungen - Google Patents

Absorptionsförderer für topische pharmazeutische formulierungen

Info

Publication number
DE69434199D1
DE69434199D1 DE69434199T DE69434199T DE69434199D1 DE 69434199 D1 DE69434199 D1 DE 69434199D1 DE 69434199 T DE69434199 T DE 69434199T DE 69434199 T DE69434199 T DE 69434199T DE 69434199 D1 DE69434199 D1 DE 69434199D1
Authority
DE
Germany
Prior art keywords
pharmaceutical formulations
topical pharmaceutical
absorption conveyor
conveyor
absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69434199T
Other languages
English (en)
Other versions
DE69434199T2 (de
Inventor
Servet Bueyuektimkin
Nadir Bueyuektimkin
Howard Rytting
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Odontex Inc
Original Assignee
Odontex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Odontex Inc filed Critical Odontex Inc
Publication of DE69434199D1 publication Critical patent/DE69434199D1/de
Application granted granted Critical
Publication of DE69434199T2 publication Critical patent/DE69434199T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69434199T 1993-10-07 1994-10-07 Absorptionsförderer für topische pharmazeutische formulierungen Expired - Lifetime DE69434199T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13345493A 1993-10-07 1993-10-07
US133454 1993-10-07
PCT/US1994/011597 WO1995009590A1 (en) 1993-10-07 1994-10-07 Absorption enhancers for topical pharmaceutical formulations

Publications (2)

Publication Number Publication Date
DE69434199D1 true DE69434199D1 (de) 2005-01-27
DE69434199T2 DE69434199T2 (de) 2005-12-29

Family

ID=22458697

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434199T Expired - Lifetime DE69434199T2 (de) 1993-10-07 1994-10-07 Absorptionsförderer für topische pharmazeutische formulierungen

Country Status (10)

Country Link
EP (1) EP0746294B1 (de)
CN (1) CN1133465C (de)
AT (1) ATE285212T1 (de)
AU (1) AU7977294A (de)
CA (1) CA2178594C (de)
DE (1) DE69434199T2 (de)
ES (1) ES2233933T3 (de)
PT (1) PT746294E (de)
RU (1) RU2165265C2 (de)
WO (1) WO1995009590A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295797B6 (cs) * 1997-04-04 2005-11-16 Bochemie, S.R.O. Sloučeniny na bázi derivátů omega-aminokyselin, způsob jejich výroby a jejich použití
JP4540667B2 (ja) * 2003-03-21 2010-09-08 ネクスメツド・ホールデイングス・インコーポレイテツド 抗真菌性ネイルコート
WO2004089381A1 (en) 2003-04-02 2004-10-21 Nexmed (Holdings), Inc. Prostaglandin compositions and their use for the treatment of vasospasm
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
RU2007125978A (ru) 2004-12-10 2009-01-20 Талима Терапьютикс, Инк. (Us) Композиции и способы для лечения заболеваний ногтей
MX2010009148A (es) * 2008-02-28 2010-12-06 Toray Industries Composicion farmaceutica para la administracion transnasal.
US8697074B2 (en) * 2008-07-10 2014-04-15 Esbatech, An Alcon Biomedical Research Unit Llc Methods and compositions for enhanced delivery of macromolecules
CN107320732B (zh) * 2008-12-04 2021-09-07 于崇曦 高穿透性组合物及其应用
WO2012139033A1 (en) 2011-04-07 2012-10-11 Nexmed Holdings, Inc. Methods and compositions for treating raynaud's disease
DE102013004199A1 (de) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische Zusammensetzung
EP2968886A1 (de) 2013-03-14 2016-01-20 Hallux, Inc. Verfahren zur behandlung von infektionen, krankheiten oder störungen der nägel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
US4732892A (en) * 1985-07-12 1988-03-22 American Home Products Corporation L-α-amino acids as transdermal penetration enhancers
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
US4980378A (en) * 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
WO1992016236A1 (en) * 1991-03-19 1992-10-01 Rajadhyaksha Vithal J Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers

Also Published As

Publication number Publication date
AU7977294A (en) 1995-05-01
ATE285212T1 (de) 2005-01-15
EP0746294A4 (de) 1998-04-22
CN1140983A (zh) 1997-01-22
RU2165265C2 (ru) 2001-04-20
CA2178594A1 (en) 1995-04-13
EP0746294B1 (de) 2004-12-22
EP0746294A1 (de) 1996-12-11
WO1995009590A1 (en) 1995-04-13
CA2178594C (en) 2008-12-23
DE69434199T2 (de) 2005-12-29
CN1133465C (zh) 2004-01-07
PT746294E (pt) 2005-03-31
ES2233933T3 (es) 2005-06-16

Similar Documents

Publication Publication Date Title
ATE179612T1 (de) Hochdosierte topische kollagenaseformen
LV11279A (lv) Farmaceitiska kompozicija kas satur nervu augsanas faktoru
DE69434199D1 (de) Absorptionsförderer für topische pharmazeutische formulierungen
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
ES2103563T3 (es) Esteres nitricos con una actividad farmacologica y procedimiento para su preparacion.
UA11237A (uk) Спосіб одержаhhя hітрогліцериhу в формі аерозолю
DE69332350D1 (de) Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen
SE8702941D0 (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
ATE94765T1 (de) Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen.
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
NO934107D0 (no) Penetrasjonsfremmende substans
FI962354A0 (fi) Pitkävaikutteisia ruiskesuspensioita ja menetelmä niiden valmistamiseksi
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
DE3776111D1 (de) Pharmazeutische zubereitungen.
ES2078256T3 (es) Formula farmaceutica para uso topico que contiene diclofenaco sodico.
DE3881254D1 (de) Pharmazeutische zusammensetzung.
TR199701463T1 (en) Sorbin asiti i�eren hidrojel.
MX9303606A (es) Derivados de azabicicloheptano n-sustituidos, su obtencion y uso.
MX9205702A (es) Composicion que comprende un material de tramadol y acetaminofen y su uso.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition